Page 2026 - Coronavirus

Experts say up to 15% Covid-19 patients may also suffer kidney damage

Continuous Renal Replacement Therapy (CRRT) a term used for a collection of acute dialysis techniques can support these patients for 24 hours in a day

Dr Reddy's denies reports it is in talks with Gilead for Covid-19 antiviral

Patient groups urge govt to revoke Gilead's remedesivir patent in the wake of the crisis

India has to play its cards well in post-coronavirus world

A new war of invisible type is now going on against mankind. Each country will have to select its side. But more importantly, develop its one offense and defensive frameworks

How will new lockdown guidelines impact different sectors of the economy?

The services such as aviation, hotels, malls, etc. would have to wait for a much longer time

US has 'passed the peak' on new coronavirus cases, says Donald Trump

The US has over 637,000 confirmed Covid-19 cases and over 30,826 deaths, the highest for any country in the world

'Jokers' flouting lockdown, attacking doctors, nurses anti-human: Salman

The actor said that whoever does not understand a coronavirus positive patient's pain is anti-human.

Covid-19: Asia's growth may see first halt in 60 years in 2020, says IMF

sia's economy is likely to suffer zero growth this year for the first time in 60 years, the IMF said in a report on the Asia-Pacific region

RPG Life Sciences delivers life-saving drugs directly to patients

Despite the pharmaceutical industry having the essential commodities tag, the administration, police and building societies was not allowing movement of people and products

Six Indian cos working on Covid-19 vaccine; ramp up testing, say experts

As Covid-19 infects more than 1.9 million in the world and claims 1,26,000 lives, Indian scientists are also part of the global fight against the disease

Nifty unlikely to go past 10,000 anytime soon, keep buying at low levels

For investment, buy in the range of 7,000-10,000 Nifty level - buy 5% at the 10,000 level; raise to 10% at 9,500; to 15% at 9,000; and then keep adding gradually at lower levels

Meet GISAID, the open science database helping us make sense of Covid-19

The philosophy of open science is informed by the idea that research communities must share socially useful knowledge, including scientific research, freely and without charge

Google slows new hiring due to Covid-19, looks to invest in strategic areas

This has been the most drastic action by the web search giant since the Covid-19 pandemic began battering its advertising business several weeks ago

Indian High Commission in UK hosts Covid-19 virtual meet for businesses

The government of India and the High Commission of India are constantly working in consultation with businesses and business organisations with regard to the government's response to Covid-19

Amazon's EU head resigns after French court orders to limit deliveries

Perticucci joined Amazon in 2013, according to his profile on LinkedIn, and his departure comes at a time when the company is planning to close its warehouses in France until at least early next week.

Retail needs therapy: Future and fortunes of a business after coronavirus

Modern, organised retail is bleeding as the coronavirus pandemic keeps India indoors and shuttered. Arvind Singhal explains what it will take to get this business back on its feet

McKinsey to medical kits: How states in US are planning to reopen economy

As of Wednesday evening, the novel coronavirus had infected over 630,000 Americans and resulted in over 28,000 deaths domestically, according to Johns Hopkins University

Govt rules to revive rural economy in lockdown miss out details: Experts

Guidelines allow some farming from April 20 during the national lockdown to contain the coronavirus.

IT stocks slide after Wipro's weak Q4 show; TCS slips 2% ahead of results

Infosys was trading nearly 4 per cent lower at Rs 614.75 while Tech Mahindra was down over 3 per cent

28,941 samples tested on April 15, says ICMR; WHO lauds health ministry

ICMR has also issued a list of 176 government laboratories and 78 private laboratories for the coronavirus testing

TCS Q4 preview: Covid-19 likely to hit most verticals; FY21 outlook key

Net sales (revenue), according to Centrum Broking, is expected to see 1.5 per cent sequential growth at Rs 40,436.9 crore.